MoneyWorks4Me

Laurus Labs informs about company updates

19 Aug 2017 Evaluate

Laurus Labs has informed that US Food and Drug Administration (USFDA) has completed inspection of API facilities in Unit 1 and 3 in Parawada, Visakhapatnam, Andhra Pradesh, with two observations. This is a regular surveillance audit by USFDA, and the observations are procedural in nature and no data integrity issues were observed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1753.90
Dr. Reddys Labs. 1217.35
Cipla 1325.00
Lupin 1957.60
Zydus Lifesciences 1136.30
View more..